Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
pharmaphorum pharmaphorum Industry leading publications, strategic consulting and a content-driven stakeholder engagement agency Published Jan 19, 2026 In this weeks Top Stories, we look back at the FDA asking manufacturers of GLP-1 drugs used for weight loss to remove warnings of suicidal thinking, but adding febrile seizure warnings to flu shots
Also, with the popularity of these drugs soaring, the need for long-term safety data is paramount to ensure weight loss does not come at the cost of overall well-being.
10.1007/s00125-013-3039-1 117
Retatrutide carries the same gastric emptying interactions plus additional considerations from the glucagon component
The effect of acetyl-L-carnitine administration on persons with Down syndrome
